Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T

• Verfasst von: Loi, Lisa [VerfasserIn]
• Verfasst von: Zimmermann, Ferdinand [VerfasserIn]
• Verfasst von: Görke, Steffen [VerfasserIn]
• Verfasst von: Korzowski, Andreas [VerfasserIn]
• Verfasst von: Meißner, Jan-Eric [VerfasserIn]
• Verfasst von: Deike-Hofmann, Katerina [VerfasserIn]
• Verfasst von: Stieber, Anne [VerfasserIn]
• Verfasst von: Bachert, Peter [VerfasserIn]
• Verfasst von: Ladd, Mark E. [VerfasserIn]
• Verfasst von: Schlemmer, Heinz-Peter [VerfasserIn]
• Verfasst von: Bickelhaupt, Sebastian [VerfasserIn]
• Verfasst von: Schott, Sarah [VerfasserIn]
• Verfasst von: Paech, Daniel [VerfasserIn]
• Titel: Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T
• Verf.angabe: Lisa Loi, Ferdinand Zimmermann, Steffen Goerke, Andreas Korzowski, Jan-Eric Meissner, Katerina Deike-Hofmann, Anne Stieber, Peter Bachert, Mark Edward Ladd, Heinz-Peter Schlemmer, Sebastian Bickelhaupt, Sarah Schott, Daniel Paech
• E-Jahr: 2020
• Jahr: 24 May 2020
• Umfang: 9 S.
• Fussnoten: Gesehen am 13.08.2020
• Titel Quelle: Enthalten in: European journal of radiology
• Ort Quelle: Amsterdam [u.a.] : Elsevier Science, 1990
• Jahr Quelle: 2020
• Band/Heft Quelle: 129(2020), Artikel-ID 109068, Seite 1-9
• ISSN Quelle: 1872-7727
• DOI: doi:10.1016/j.ejrad.2020.109068
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: 7 Tesla MRI
• Sach-SW: APT CEST
• Sach-SW: AREX
• Sach-SW: Breast cancer
• Sach-SW: Fat-correction
• Sach-SW: Guanidyl CEST
• K10plus-PPN: 1726987779

Abstract

Purpose - To investigate whether fat-corrected and relaxation-compensated amide proton transfer (APT) and guanidyl CEST-MRI enables the detection of signal intensity differences between breast tumors and normal-appearing fibroglandular tissue in patients with newly-diagnosed breast cancer. - Method - Ten patients with newly-diagnosed breast cancer and seven healthy volunteers were included in this prospective IRB-approved study. CEST-MRI was performed on a 7T-whole-body scanner followed by a multi-Lorentzian fit analysis. APT and guanidyl CEST signal intensities were quantified in the tumor and in healthy fibroglandular tissue after correction of B0/B1-field inhomogeneities, fat signal contribution, T1- and T2-relaxation; signal intensity differences of APT and guanidyl resonances were compared using Mann-Whitney-U-tests. Pearson correlations between tumor CEST signal intensities and the proliferation index Ki-67 were performed. - Results - APT CEST signal in tumor tissue (6.70±1.38%Hz) was increased compared to normal-appearing fibroglandular tissue of patients (3.56±0.54%Hz, p=0.001) and healthy volunteers (3.70±0.68%Hz, p=0.001). Further, a moderate positive correlation was found between the APT signal and the proliferation index Ki-67 (R2=0.367, r=0.606, p=0.11). Guanidyl CEST signal was also increased in tumor tissue (5.24±1.85%Hz) compared to patients’ (2.42±0.45%Hz, p=0.006) and volunteers’ (2.36±0.54%Hz, p<0.001) normal-appearing fibroglandular tissue and a positive correlation with the Ki-67 level was observed (R2=0.365, r=0.604, p=0.11). APT and guanidyl CEST signal in normal-appearing fibroglandular tissue was not different between patients and healthy volunteers (p=0.88; p=0.93). - Conclusion - Relaxation-compensated and fat-corrected CEST-MRI allowed a non-invasive differentiation of breast cancer and normal-appearing breast tissue. Thus, this approach represents a contrast agent-free method that may help to increase diagnostic accuracy in MR-mammography.